The UCL Institute of Orthopaedics and Musculoskeletal Science (IOMS) has an international reputation and a track record for innovative translational research. IOMS provides a unique environment for collaboration between scientists, engineers, and clinicians in an Academic Health Sciences Centre model, in order to speed the development of improvements in patient care.

    IOMS and staff from the Royal National Orthopaedic Hospital lead units of major importance in clinical care and are at the cutting edge of research and development in novel prostheses development; cell-engineering; spinal surgery; osteoporosis; nerve injuries; and diseases of childhood.

    Ideas from IOMS have been successfully taken through commercialisation, for example in the UCL Spin-out, Stanmore Implants Worldwide, which is now a fast growing global player in the orthopaedic implant market.

    IOMS interacts with several other UCL divisions and departments helping to drive forward the musculoskeletal agenda and is part of the UCL CHAPTER which combines electronic health records with other forms of research data to unlock better healthcare. Many of our team are also part of the UCL of Institute of Biomedical Engineering (IBME) and the London Implant Retrieval Centre (LIRC), which helps understand how best to optimise performance of joint replacements.

    There is also a very active Masters education programme for postgraduate students and many graduates have gone on to become national and international thought leaders and influencers in the field.

    Professor Gordon Blunn: Institute Director and Professor of Orthopaedic Sciences

    Dr Vivek Mudera: Institute Director of Education

    homepage footer

    Page last modified on 03 mar 14 11:52